DIVISLABBSEDivis Laboratories LtdHighPositive
Announced Sat, 23 May · 12:56 IST

The Board of Directors at its meeting held on May 23, 2026 have recommended a dividend of Rs. 30/- per share (i.e. @1500%), subject to approval at the ensuing Annual General Meeting.

Corporate Actions View source PDF

DIVISLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.3%1-day move
₹6900.00
prior close
₹6750.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+1.1+1.4+1.1+2.0-2.3-1.6-3.2-5.0-5.7-4.6-2.5-2.9+7.8
Up moveDown movePending
AI summary

Divis Laboratories Board recommended a final dividend of Rs. 30 per share (1500% on face value of Rs. 2) for FY 2025-26, subject to shareholder approval at the 36th AGM on August 10, 2026. The record date for dividend eligibility is July 24, 2026. For the full year, consolidated profit after tax rose 17% to Rs. 2,568 crore on total income of Rs. 11,067 crore. Standalone PAT grew 18% to Rs. 2,607 crore. The company reported forex gains of Rs. 211 crore for the year. Capital expenditure was substantial at Rs. 2,520 crore, with working capital increases in inventories and receivables. The dividend amount matches last year's payout of Rs. 30 per share.

Likely market impact

The maintained dividend at Rs. 30 per share signals financial stability and shareholder-friendly approach despite heavy capex. The 17% PAT growth and strong forex gains indicate robust operational performance, which could support the stock price ahead of the record date.